Effect of the Active Layer Thickness on the Device Performance of Polymer Solar Cells Having [60]PCBM and [70]PCBM as Electron Acceptor

Abstract Recently it has been shown that the use of [70]PCBM as electron acceptor in polymer solar cells can improve the current output of such devices because C70 derivatives have a stronger and broader absorption compared to C60 ones. In this work we studied the influence of the fullerene on the optical behaviour of the photoactive blend film of a polymer solar cell. We simulated the optical absorption of the active layer inside the device structure and we calculated the maximum achievable short circuit current density with the aim to correlate the variation of the optical constants to the output current of the device. Afterward, we realized several polymer solar cells and we proved the theoretical findings

Genetic variants of Y chromosome are associated with a protective lipid profile in black men

Objective— Gender and ethnicity modulate the phenotypic expression of cardiovascular risk factors. In particular, men are at higher risk of developing cardiovascular diseases compared to women, whereas black populations of African origin display reduced mortality from coronary heart disease (CHD) as compared to both whites and South Asians. Because the male-specific region (MSY) of the human Y chromosome is an obvious candidate for gender-related differences in the development of cardiovascular diseases, we aimed to identify genetic variants of MSY influencing cardiovascular risk profile in different ethnic groups. Methods and Results— We genotyped 4 polymorphisms of MSY (HindIII±, rs768983 of TBL1Y, rs3212292 of USP9Y, and rs9341273 of UTY genes) in 579 men of different ethnic groups (blacks, South Asians, and whites) from UK and in 301 whites in Italy. We found that the TBL1YA USP9YA haplotype, present only in blacks in whom it represents the most frequent allelic combinations (AA: n=125; all other combinations: n=45), was associated with lower levels of triglycerides (P=0.025) and higher levels of HDL-cholesterol (P=0.005) as compared to the other haplotypes. Conclusion— The TBL1YA USP9YA haplotype of the Y chromosome, present only in black people of African origin, attributes a favorable lipoprotein pattern, likely to contribute to their reduced susceptibility to coronary heart disease. The study evaluated the association of genetic variants of the male-specific region of the Y chromosome with cardiovascular risk factors in different ethnic groups. The most frequently observed haplotype in black people was associated with a favorable lipoprotein pattern, thus contributing to the lower rate of cardiovascular diseases in blacks

Low-Density EEG Correction With Multivariate Decomposition and Subspace Reconstruction

A hybrid method is proposed for removing artifacts from electroencephalographic (EEG) signals. This relies on the integration of artifact subspace reconstruction (ASR) with multivariate empirical mode decomposition (EMD). The method can be applied when few EEG sensors are available, a condition in which existing techniques are not effective, and it was tested with two public datasets: 1) semisynthetic data and 2) experimental data with artifacts. One to four EEG sensors were taken into account, and the proposal was compared to both ASR and multivariate EMD (MEMD) alone. The proposed method efficiently removed muscular, ocular, or eye-blink artifacts on both semisynthetic and experimental data. Unexpectedly, the ASR alone also showed compatible performance on semisynthetic data. However, ASR did not work properly when experimental data were considered. Finally, MEMD was found less effective than both ASR and MEMD-ASR

Smart Glasses for Visually Evoked Potential Applications: Characterisation of the Optical Output for Different Display Technologies

Off-the-shelf consumer-grade smart glasses are being increasingly used in extended reality and brain–computer interface applications that are based on the detection of visually evoked potentials from the user’s brain. The displays of these kinds of devices can be based on different technologies, which may affect the nature of the visual stimulus received by the user. This aspect has substantial impact in the field of applications based on wearable sensors and devices. We measured the optical output of three models of smart glasses with different display technologies using a photo-transducer in order to gain insight on their exploitability in brain–computer interface applications. The results suggest that preferring a particular model of smart glasses may strongly depend on the specific application requirements

Active and Passive Brain-Computer Interfaces Integrated with Extended Reality for Applications in Health 4.0

This paper presents the integration of extended reality (XR) with brain-computer interfaces (BCI) to open up new possibilities in the health 4.0 framework. Such integrated systems are here investigated with respect to an active and a passive BCI paradigm. Regarding the active BCI, the XR part consists of providing visual and vibrotactile feedbacks to help the user during motor imagery tasks. Therefore, XR aims to enhance the neurofeedback by enhancing the user engagement. Meanwhile, in the passive BCI, user engagement monitoring allows the adaptivity of a XR-based rehabilitation game for children. Preliminary results suggest that the XR neurofeedback helps the BCI users to carry on motor imagery tasks with up to 84% classification accuracy, and that the level of emotional and cognitive engagement can be detected with an accuracy greater than 75%

HIV-1 induces in vivo platelet activation by enhancing platelet NOX2 activity.

OBJECTIVES: HIV-1 patients show increased platelet activation, but the mechanisms involved are not completely clarified. We speculated that HIV-1 might induce in vivo platelet activation by enhancing platelet NOX2-related oxidative stress. METHODS: We measured soluble CD40 Ligand (sCD40L), a systemic marker of platelet activation, in 36 HIV-1 patients under effective combined antiretroviral therapy (cART) and in 10 naïve HIV-1 subjects. As control, 20 healthy subjects (HS) were included. Platelet oxidative stress was measured by platelet NOX2-derived peptide (sNOX2-dp), p47(phox) translocation to platelet membrane and platelet prostaglandin F2α (8-iso-PGF2α). RESULTS: sCD40L was increased both in HIV-1 naïve and cART patients compared to HS (p < 0.001). Platelet sNOX2-dp and 8-iso-PGF2α were significantly higher in HIV-1 naïve subjects compared to those on cART and to HS, and both were mutually correlated (R = 0.734, p < 0.001). A stepwise multivariable linear regression analysis showed that platelet sNOX2-dp (β: 0.803, p < 0.001), HIV-1 infection (β: 0.146, p = 0.014) and age (β: 0.166, p = 0.001) were independently associated to sCD40L levels. CONCLUSIONS: HIV-1 infection is associated with increased platelet oxidative stress, which was related to the activation of NOX2. The independent association between platelet NOX2 activation and plasma levels of sCD40L suggest that in vivo platelet activation may be dependent upon platelet oxidative stress

Pyridostigmine in pediatric Intestinal pseudo-obstruction. case report of a 2-year old girl and literature review

Pediatric chronic intestinal pseudo-obstruction is a rare disorder characterized by a severe impairment of gastrointestinal motility leading to intestinal obstruction symptoms in the absence of mechanical causes. The diagnosis is usually clinical and diagnostic work is usually aimed to rule out mechanical obstruction and to identify any underlying diseases. Treatment is challenging and requires a multidisciplinary effort. In this manuscript we describe the youngest child successfully treated with the orally administrable, longacting, reversible anti-cholinesterase drug, pyridostigmine. Like other drugs belonging to cholinesterase inhibitors, pyridostigmine enhances gut motility by increasing acetylcholine availability in the enteric nervous system and neuro-muscular junctions. Based on the direct evidence from the reported case, we reviewed the current literature on the use of pyridostigmine in severe pediatric dysmotility focusing on intestinal pseudo-obstruction. The overall data emerged from the few published studies suggest that pyridostigmine is an effective and usually well tolerated therapeutic options for patients with intestinal pseudo-obstruction. More specifically, the main results obtained by pyridostigmine included marked reduction of abdominal distension, reduced need of parenteral nutrition, and improvement of oral feeding. The present case and review on pyridostigmine pave the way for eagerly awaited future randomized controlled studies testing the efficacy of cholinesterase inhibitors in pediatric severe gut dysmotility

The use of β-blockers in patients with heart failure and comorbidities: Doubts, certainties and unsolved issues.

β-blockers represent a mainstay in the pharmacological approach to patients affected by heart failure with reduced ejection fraction (HFrEF). However, underuse of this class of drugs is still reported, especially in the presence of cardiovascular and non-cardiovascular comorbidities, even if they are not contraindications for prescription of a β-blocker. The prognostic benefit of β-blockers is relevant in the presence of comorbidities, and achievement of the maximum tolerated dose is an important goal to increase their favorable prognostic role. The aim of the present review is to analyze the available evidence on the use of β-blockers in HFrEF patients with the most common comorbidities. In particular, we will discuss the role and most appropriate beta-blocker in patients with pulmonary disease (bisoprolol, metoprolol, nebivolol), diabetes (carvedilol and nebivolol), atrial fibrillation (all indicated for rate control, with metoprolol as the first choice followed by bisoprolol, nebivolol, and carvedilol), erectile dysfunction (bisoprolol and nebivolol), peripheral arterial disease (nebivolol), and other conditions, in order to clarify the correct use of this class of drugs in the clinical practice